Neurometrix Company Profile (NASDAQ:NURO)

About Neurometrix

Neurometrix logoNeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NURO
  • CUSIP:
Key Metrics:
  • Previous Close: $0.63
  • 50 Day Moving Average: $0.7062
  • 200 Day Moving Average: $1.1335
  • 52-Week Range: $0.58 - $2.36
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.64
  • P/E Growth: -0.0500
  • Market Cap: $4.99M
  • Outstanding Shares: 7,914,000
  • Beta: 0.1
Profitability:
  • Net Margins: -124.01%
  • Return on Equity: -181.47%
  • Return on Assets: -129.09%
Debt:
  • Current Ratio: 2.29%
  • Quick Ratio: 1.91%
Additional Links:
Companies Related to Neurometrix:

Analyst Ratings

Consensus Ratings for Neurometrix (NASDAQ:NURO) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.50 (604.23% upside)

Analysts' Ratings History for Neurometrix (NASDAQ:NURO)
Show:
DateFirmActionRatingPrice TargetDetails
10/23/2016HC WainwrightReiterated RatingBuy$4.50View Rating Details
10/21/2016Rodman & RenshawReiterated RatingBuy$4.50View Rating Details
2/29/2016Dawson JamesReiterated RatingBuyView Rating Details
9/11/2015Maxim GroupInitiated CoverageBuy$8.00View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Neurometrix (NASDAQ:NURO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/19/2017        
1/26/2017Q416($0.75)($0.52)$3.48 million$3.70 millionViewListenView Earnings Details
10/20/2016Q316($0.82)($0.76)$3.01 million$3.39 millionViewListenView Earnings Details
7/21/2016Q216($0.93)($5.37)$1.22 million$2.65 millionViewListenView Earnings Details
4/21/2016Q116($0.95)($1.00)$2.65 million$2.28 millionViewListenView Earnings Details
10/22/2015Q315($0.08)($0.26)$6.47 million$2.10 millionViewListenView Earnings Details
7/22/2015Q215($0.48)$9.80 million$1.22 millionViewListenView Earnings Details
4/21/2015Q115($0.25)$1.33 million$1.28 millionViewListenView Earnings Details
2/12/2015Q414($0.36)$4.62 million$1.41 millionViewN/AView Earnings Details
10/28/2014Q314($0.19)$1.31 million$1.43 millionViewN/AView Earnings Details
7/24/2014Q413($0.85)$1.16 million$1.34 millionViewN/AView Earnings Details
2/13/2014($0.87)ViewListenView Earnings Details
10/23/2013Q313($0.26)$1.77 million$1.31 millionViewListenView Earnings Details
7/25/2013Q2 2013($0.92)$2.20 million$1.20 millionViewN/AView Earnings Details
2/3/2011($0.17)($0.18)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neurometrix (NASDAQ:NURO)
Current Year EPS Consensus Estimate: $-0.930 EPS
Next Year EPS Consensus Estimate: $-0.390 EPS

Dividends

Dividend History for Neurometrix (NASDAQ:NURO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neurometrix (NASDAQ:NURO)
Insider Ownership Percentage: 5.90%
Institutional Ownership Percentage: 6.14%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2016Shai GozaniCEOBuy3,000$1.31$3,930.00View SEC Filing  
10/28/2016Thomas T HigginsInsiderBuy3,000$1.32$3,960.00View SEC Filing  
10/27/2016Shai GozaniCEOBuy6,000$1.32$7,920.00View SEC Filing  
8/31/2016Thomas T HigginsCFOBuy1,400$1.41$1,974.00View SEC Filing  
8/18/2016Shai GozaniCEOBuy5,000$1.49$7,450.00View SEC Filing  
8/12/2016Thomas T HigginsInsiderBuy2,000$1.45$2,900.00View SEC Filing  
6/1/2016Shai GozaniCEOBuy2,500$1.71$4,275.00View SEC Filing  
5/23/2016Francis X McgillinVPBuy1,000$1.65$1,650.00View SEC Filing  
5/19/2016Shai GozaniCEOBuy12,000$1.55$18,600.00View SEC Filing  
5/19/2016Thomas T HigginsCFOBuy3,200$1.54$4,928.00View SEC Filing  
8/28/2015Thomas T HigginsCFOBuy4,500$0.92$4,140.00View SEC Filing  
8/20/2015Thomas T HigginsCFOBuy5,500$0.91$5,005.00View SEC Filing  
8/11/2015Shai GozaniCEOBuy16,300$0.91$14,833.00View SEC Filing  
11/9/2012Shai GozaniCEOBuy26,800$0.55$14,740.00View SEC Filing  
8/27/2012Krishnamurthy BalachandranCOOBuy5,000$0.67$3,350.00View SEC Filing  
8/21/2012Thomas T HigginsCFOBuy5,000$0.64$3,200.00View SEC Filing  
8/13/2012Krishnamurthy BalachandranCOOBuy5,000$0.70$3,500.00View SEC Filing  
8/8/2012Thomas T HigginsCFOBuy5,000$0.70$3,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Neurometrix (NASDAQ:NURO)
DateHeadline
News IconTrading Center: Watching Shares of NeuroMetrix Inc (NURO) - The Standard (NASDAQ:NURO)
6milestandard.com - February 24 at 8:01 PM
News IconNeurometrix Inc (NASDAQ:NURO) Announces Availability of Quell Wearable Pain Relief Technology At Best Buy - Traders350 (NASDAQ:NURO)
traders350.com - February 24 at 8:01 PM
finance.yahoo.com logoNeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Best Buy (NASDAQ:NURO)
finance.yahoo.com - February 21 at 5:57 PM
News IconNeuroMetrix Inc NURO Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:NURO)
www.bioportfolio.com - February 18 at 11:52 AM
News IconMarket Scout: Looking at the Levels for NeuroMetrix Inc. (NURO) - Baxter Review (NASDAQ:NURO)
baxternewsreview.com - February 17 at 8:22 AM
finance.yahoo.com logoNEUROMETRIX, INC. Financials (NASDAQ:NURO)
finance.yahoo.com - February 16 at 6:30 PM
finance.yahoo.com logoNEUROMETRIX, INC. Financials (NASDAQ:NURO)
finance.yahoo.com - February 16 at 6:30 PM
News IconAre Insiders Pocketing Their Own Shares of NeuroMetrix, Inc. (NASDAQ:NURO)? - Winfield Review (NASDAQ:NURO)
winfieldreview.com - February 13 at 8:08 PM
News IconMarket Scout: Looking at the Levels for NeuroMetrix Inc. (NURO) - Davidson Register (NASDAQ:NURO)
davidsonregister.com - February 10 at 7:51 PM
biz.yahoo.com logoNEUROMETRIX, INC. Files SEC form 10-K, Annual Report (NASDAQ:NURO)
biz.yahoo.com - February 9 at 7:59 PM
biz.yahoo.com logoNEUROMETRIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; (NASDAQ:NURO)
biz.yahoo.com - February 8 at 7:51 PM
realistinvestor.com logoNeuroMetrix, Inc. (NASDAQ:NURO) EPS Projection At $-0.16 - RealistInvestor.com (NASDAQ:NURO)
www.realistinvestor.com - February 5 at 6:42 PM
News IconAre Insiders Bumping Up Their Positions in NeuroMetrix, Inc. (NASDAQ:NURO) - Wall Street Beacon (NASDAQ:NURO)
wsbeacon.com - January 31 at 5:38 AM
capitalcube.com logoNeuroMetrix, Inc. :NURO-US: Earnings Analysis: 2016 By the Numbers : January 27, 2017 (NASDAQ:NURO)
www.capitalcube.com - January 28 at 5:17 AM
us.rd.yahoo.com logoNeuroMetrix Reports Q4 and Full Year 2016 Financial Results (NASDAQ:NURO)
us.rd.yahoo.com - January 26 at 11:44 PM
biz.yahoo.com logoQ4 2016 NeuroMetrix Inc Earnings Release - Before Market Open (NASDAQ:NURO)
us.rd.yahoo.com - January 26 at 11:44 PM
biz.yahoo.com logoNEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit (NASDAQ:NURO)
us.rd.yahoo.com - January 26 at 11:43 PM
us.rd.yahoo.com logo7:20 am NeuroMetrix reports Q4 results; rev +36% y/y to $3.7 mln (NASDAQ:NURO)
us.rd.yahoo.com - January 26 at 11:43 PM
biz.yahoo.com logoNeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today (NASDAQ:NURO)
biz.yahoo.com - January 26 at 11:43 PM
News IconShares in View: NeuroMetrix Inc. (NURO) - Sherwood Daily (NASDAQ:NURO)
sherwooddaily.com - January 25 at 9:58 PM
News IconReviewing Indicator Levels for NeuroMetrix Inc. (NURO) - Sherwood Daily (NASDAQ:NURO)
sherwooddaily.com - January 25 at 12:44 AM
News IconIs There Any Upside to This Stock Under $5: NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - January 24 at 9:00 AM
realistinvestor.com logoNeuroMetrix, Inc. (NASDAQ:NURO) EPS Estimate At $-0.2 - RealistInvestor.com (NASDAQ:NURO)
www.realistinvestor.com - January 24 at 9:00 AM
News IconAre Insiders Filling Their Own Pockets With Shares? Insider Update on NeuroMetrix, Inc. (NASDAQ:NURO) - Wall Street Beacon (NASDAQ:NURO)
wsbeacon.com - January 24 at 9:00 AM
News IconTrading Radar: Checking Technicals for NeuroMetrix Inc. (NURO) - Sherwood Daily (NASDAQ:NURO)
sherwooddaily.com - January 24 at 9:00 AM
News IconNeuroMetrix Announces Date For 2016 Full Year And Fourth Quarter Financial Results Conference Call (NASDAQ:NURO)
www.biospace.com - January 21 at 6:42 PM
News IconAre the Technicals Adding up for NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - January 20 at 7:44 PM
finance.yahoo.com logoNeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call (NASDAQ:NURO)
finance.yahoo.com - January 20 at 7:44 PM
News IconStock Overview: Moving Average Check on NeuroMetrix Inc. (NURO) - Sherwood Daily (NASDAQ:NURO)
sherwooddaily.com - January 20 at 4:29 AM
News IconAre There Any Catalysts to Propel This Stock Forward: NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - January 20 at 4:29 AM
News IconSpot-check on CCI and RSI for NeuroMetrix Inc. (NURO) - Sherwood Daily (NASDAQ:NURO)
sherwooddaily.com - January 18 at 9:02 AM
News IconPlacing the Bulls-Eye Focus on NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - January 18 at 9:02 AM
News IconMarkets End Mostly Higher, How Did This Stock Fare: NeuroMetrix, Inc. (NASDAQ:NURO) - Wall Street Beacon (NASDAQ:NURO)
wsbeacon.com - January 14 at 7:00 PM
finance.yahoo.com logo7:01 am NeuroMetrix reports Q4 demand for its Quell Technology, invoiced value of shipments totaled approximately $3.5 mln (+19% Q/Q) (NASDAQ:NURO)
finance.yahoo.com - January 10 at 7:49 PM
seekingalpha.com logoNeuroMetrix says Quell up 19% sequentially in Q4 - Seeking Alpha (NASDAQ:NURO)
seekingalpha.com - January 10 at 8:54 AM
finance.yahoo.com logoNeuroMetrix Reports Strong Quell Demand in Q4 2016 (NASDAQ:NURO)
finance.yahoo.com - January 10 at 8:54 AM
News IconKeen Investors Taking a Look at NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - January 9 at 7:36 PM
News IconNeuroMetrix Inc NURO Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:NURO)
www.bioportfolio.com - January 8 at 6:39 PM
News IconBargain or Bait? Stock Update on NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - January 7 at 5:42 AM
publicnow.com logoNeuroMetrix to Present at the Digital Medicine Showcase 2017: At the Intersection of Technology and Medicine (NASDAQ:NURO)
www.publicnow.com - January 6 at 7:38 PM
News IconStreetwise Investors Taking Note of NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - January 5 at 10:34 PM
publicnow.com logoNeuroMetrix Closes $7.0 Million Private Placement of Preferred Stock and Warrants (NASDAQ:NURO)
www.publicnow.com - January 5 at 10:34 PM
publicnow.com logoCES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain (NASDAQ:NURO)
us.rd.yahoo.com - January 3 at 10:13 PM
businesswire.com logoNeuroMetrix to Present at Biotech Showcase 2017 - Business Wire (press release) (NASDAQ:NURO)
www.businesswire.com - January 3 at 5:11 PM
News IconNotable Stock For Under $5: NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - January 3 at 5:11 PM
News IconAre These Shares a Bargain: Update on NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - January 3 at 5:11 PM
publicnow.com logoNeuroMetrix to Present at Biotech Showcase 2017 (NASDAQ:NURO)
www.publicnow.com - January 3 at 5:11 PM
streetinsider.com logoNeuroMetrix (NURO) Enters $7M Private Placement of Preferred ... - StreetInsider.com (NASDAQ:NURO)
www.streetinsider.com - December 28 at 11:49 PM
publicnow.com logoNeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock and Warrants (NASDAQ:NURO)
www.publicnow.com - December 28 at 6:47 PM
News IconPrepping for a Big Move? Share Update on NeuroMetrix, Inc. (NASDAQ:NURO) - Prospect Journal (NASDAQ:NURO)
prospectjournal.com - December 24 at 12:08 AM

Social

What is Neurometrix's stock symbol?

Neurometrix trades on the NASDAQ under the ticker symbol "NURO."

When did Neurometrix's stock split? How did Neurometrix's stock split work?

Shares of Neurometrix reverse split on Wednesday, December 2nd 2015. The 1-4 reverse split was announced on Tuesday, December 1st 2015. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 1st 2015. An investor that had 100 shares of Neurometrix stock prior to the reverse split would have 25 shares after the split.

Where is Neurometrix's stock going? Where will Neurometrix's stock price be in 2017?

3 equities research analysts have issued 12 month price objectives for Neurometrix's shares. Their predictions range from $4.50 to $4.50. On average, they expect Neurometrix's share price to reach $4.50 in the next year.

When will Neurometrix announce their earnings?

Neurometrix is scheduled to release their next quarterly earnings announcement on Wednesday, April, 19th 2017.

How do I buy Neurometrix stock?

Shares of Neurometrix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Neurometrix stock cost?

One share of Neurometrix stock can currently be purchased for approximately $0.64.

Neurometrix (NASDAQ:NURO) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Neurometrix (NASDAQ:NURO)

Earnings History Chart

Earnings by Quarter for Neurometrix (NASDAQ:NURO)

Dividend History Chart

Dividend Payments by Quarter for Neurometrix (NASDAQ:NURO)

Last Updated on 2/27/2017 by MarketBeat.com Staff